SEC Form 4 insider trading filings tracked in real time from EDGAR

Huntsman Ronald Kirk — Chief Executive Officer

Insider trading activity for Huntsman Ronald Kirk sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Executive Officer
  • Company: Vivos Therapeutics, Inc.
  • Total insider trades: 2
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: Sep 18, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Jun 30, 2026 Huntsman Ronald Kirk VVOS Vivos Therapeutics, Inc. OTHER 85,910 $50K
Jun 30, 2026 Huntsman Ronald Kirk VVOS Vivos Therapeutics, Inc. OTHER 85,910 $50K

← All executives · Full trades feed